Home
>
National Drug Code (NDC)
>
etomidate
etomidate - 25021-674-20 - (etomidate)
Drug Information of etomidate
| Product NDC: | 25021-674 |
| Proprietary Name: | etomidate |
| Non Proprietary Name: | etomidate |
| Active Ingredient(s): | 2 mg/mL & nbsp; etomidate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of etomidate
| Product NDC: | 25021-674 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078289 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120810 |
Package Information of etomidate
| Package NDC: | 25021-674-20 |
| Package Description: | 10 VIAL in 1 CARTON (25021-674-20) > 20 mL in 1 VIAL |
NDC Information of etomidate
| NDC Code | 25021-674-20 |
| Proprietary Name | etomidate |
| Package Description | 10 VIAL in 1 CARTON (25021-674-20) > 20 mL in 1 VIAL |
| Product NDC | 25021-674 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | etomidate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120810 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | ETOMIDATE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |
